4.4 Article

Individual- and Community-Level Factors Associated With Detectable and Elevated Blood Lead Levels in US Children Results From a National Clinical Laboratory

期刊

JAMA PEDIATRICS
卷 175, 期 12, 页码 1252-1260

出版社

AMER MEDICAL ASSOC
DOI: 10.1001/jamapediatrics.2021.3518

关键词

-

资金

  1. Quest Diagnostics
  2. National Institute of Environmental Health Sciences of the National Institutes of Health [K23ES031663]
  3. Agency for Toxic Substances and Disease Registry (ATSDR) [NU61TS000296-02]
  4. US Environmental Protection Agency [DW-75-95877701-02]

向作者/读者索取更多资源

This study suggests that, despite progress in reducing pediatric lead exposure, substantial individual- and community-level disparities persist.
IMPORTANCE No safe level of exposure to lead has been identified. OBJECTIVE To evaluate individual- and community-level factors associated with detectable and elevated blood lead levels (BLLs) in children. DESIGN, SETTING, AND PARTICIPANTS This cross-sectional, retrospective study analyzed deidentified results from blood lead tests performed at a large clinical laboratory from October 1, 2018, to February 29, 2020. Participants were 1 141 441 children younger than 6 years living in all 50 US states and the District of Columbia who underwent blood lead testing during the study period. Children who underwent lead testing of unknown source and those with elevated BLLs who received capillary blood lead testing without confirmatory venous testing were excluded. EXPOSURES Individual demographic categories included sex, age, and insurance type; community-level demographic categories included pre-1950s housing, poverty, predominant race and ethnicity, and geographical regions. MAIN OUTCOMES AND MEASURES Proportions of children with detectable (similar to 1.0 mu g/dL) and elevated (similar to 5.0 mu g/dL) BLLs, by exposure category. RESULTS Of the 1 141 441 children (586 703 boys [51.4%]; mean [SD] age, 2.3 [1.4] years) in the study, more than half of the children tested (576 092 [50.5%; 95% CI, 50.4%-50.6%]) had detectable BLLs, and 21 172 children (1.9%[95% CI, 1.8%-1.9%]) had BLLs of 5.0 mu g/dL or more. In multivariable analyses, children with public insurance had greater odds of having detectable BLLs (adjusted odds ratio [AOR], 2.01 [95% CI, 1.99-2.04]) and elevated BLLs (AOR, 1.08 [95% CI, 1.04-1.12]). The proportion of children with detectable and elevated BLLs increased significantly for progressive pre-1950s housing and poverty quintiles (P <.001). The odds of detectable BLLs were significantly higher among children in the highest vs lowest quintile of pre-1950s housing (AOR, 1.65 [95% CI, 1.62-1.68]) and of poverty (AOR, 1.89 [95% CI, 1.86-1.93]). A similar association was found for those with elevated BLLs, with an AOR of 3.06 (95% CI, 2.86-3.27) for the highest vs lowest quintile of pre-1950 housing and 1.99 (95% CI, 1.88-2.11) for the highest quintile of poverty. Children residing in zip codes with predominantly Black non-Hispanic and non-Latinx populations had higher odds of detectable BLLs (AOR, 1.13 [95% CI, 1.11-1.15]) but lower odds for elevated BLL (AOR, 0.83 [95% CI, 0.80-0.88]). CONCLUSIONS AND RELEVANCE This study suggests that, despite progress in reducing pediatric lead exposure, substantial individual- and community-level disparities persist.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据